About Index Trending news
Analyze
Top 50 Pricing
Pluristem

Pluristem

Work at Pluristem? Add yourself to this profile

Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$30,000,000
Innovative Medical Management
Grant
$3,300,000
Employees

Unknown size

Locations
HQ
Headquarters
$3,300,000 Grant
Pharmaceutical Processing

Pluristem Secures $3.3M for R&D

NoCamels

Pluristem Gets $3.3M Grant From Government

$2,900,000 Grant
pluristem

Pluristem Therapeutics Inc. - June 17, 2015 (2)